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Abstract 
Peste des Petits Ruminants (PPR) is a disease of increased attention since the eradication of Rinderpest 
virus (RPV) in 2011. PPR is an acute and highly contagious viral disease of small ruminants caused by 
a Morbillivirus named Peste des petits ruminants virus (PPRV). The devastating effects of PPR are 
mostly present in developing countries, where herding of small ruminants like goat and sheep is a major 
source of income for millions of farmers. Therefore, PPR is indubitably a disease of major  
socioeconomic impact. The FAO recently announced a program to eradicate PPR by 2030.  
The purpose of this study is to evaluate the diagnostic use of filter paper as sample medium in serol-
ogy analysis for evidence of PPR in sheep and goat in field conditions. The evaluation is performed 
alongside an epidemiologic screening of PPR antibodies in domestic small ruminants with and without 
wildlife contact in the Morogoro region, central Tanzania.  
Present study show that filter paper like Nobuto’s and Sartorius 3MM filter paper soaked with whole 
blood can be a viable alternative to serum samples, and successive serology through cELISA, in areas 
where keeping a sustained cold chain is problematic. This study also presents arguments showing how 
the interpretation of filter paper results could refine and supplement the identification of animals having 
antibodies against PPRV. Raising the cutoff value in the interpretation of positive individuals from se-
rologic analysis of filter paper samples can improve the accuracy of this method. The serologic screening 
show that PPRV infection is present in three out of three areas adjacent to the wildlife preservation area 
Selous Game Reserve. 
It is of great interest to further evaluate the use of filter paper as an alternative to serum samples in PPR 
serology to assist the study of PPR in remote areas.  
Keywords: Seroepidemiology, Seroprevalence, Filter paper, PPRV, Tanzania. 
Sammanfattning 
Peste des petits ruminants (PPR) är en sjukdom som uppmärksammats mer och mer sedan boskapspest 
utrotades 2011. PPR är en akut och mycket smittsam sjukdom hos små idisslare som orsakas av ett virus 
av genus Morbillivirus vid namn Peste des petits ruminants virus (PPRV). Den förödande effekten av 
PPR är mest påtaglig i utvecklingsländer där får- och getbesättningar är vanligt förekommande och hu-
vudinkomsten för miljontals bönder. Därför är PPR onekligen en sjukdom som medför stora socioeko-
nomiska effekter. FAO gick nyligen ut med ett officiellt program för att utrota PPR till år 2030. 
Syftet med denna studie var att utvärdera filterpapper som alternativt transportmedium för att påvisa 
antikroppar mot PPR hos får och getter. Utvärderingen utfördes parallellt med en epidemiologisk scre-
ening av antikroppar mot PPR hos små domesticerade idisslare med eller utan kontakt med vilda djur i 
Morogoro, en region i centrala Tanzania.  
Serologi på blod från filterpapper kan vara ett bra alternativ till serumprover i områden där det är pro-
blematiskt att upprätthålla kontinuerliga kylkedjor. Genom analys och statistiska uträkningar visade 
denna studie hur resultat från filterpapper bör tolkas för att upptäcka djur med antikroppar mot PPRV. 
Genom att höja gränsvärdet i tolkningen av den serologiska analysen kan säkerheten i denna metod 
förbättras. Screeningen visar att infektion med PPRV förekommer inom tre av tre områden i anslutning 
till reservatet Selous Game Reserve. 
Det är av yttersta vikt att fortsätta utvärdera filterpapper som en del i diagnostiken av PPR och som ett 
alternativ till serumprover.  
Nyckelord: Seroepidemiologi, Seroprevalens, Filterpapper, PPRV, Tanzania 
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1 Introduction 
This master thesis is a small part of an extensive three-year collaboration project between Swe-
den, Pakistan, Tanzania, Botswana, France and the UK, funded by the Swedish Research Coun-
cil (VR Developmental research grant Swedish Research Link). The aim of this larger project 
is to study the prevalence of Peste des petits ruminants virus (PPRV) in wild and domestic small 
ruminants in the wildlife-livestock interface to evaluate the role of wildlife in the epidemiology 
of the disease and virus transmission. The larger project will also investigate the complete ge-
nome sequence of PPRV and study the host’s response to infection.  
This master thesis contributes to the larger project by collecting data, performing lab work, data 
analysis, statistical analysis, and improving diagnostic methods. Funding of this master thesis 
was contributed by Swedish International Development Cooperation Agency (SIDA) and the 
Swedish University of Agricultural Sciences (SLU). 
1.1 Aims 
One of the goals with this smaller study was to evaluate the use of filter paper for serological 
diagnostics of infection with PPRV. This evaluation was performed alongside a screening of 
the seroprevalence of PPR antibodies in domestic small ruminants with or without wildlife con-
tact in Tanzania. Thus, there were two study topics in this master thesis:  
1. The evaluation of filter paper for serological diagnostics of antibodies against PPRV in
domestic small ruminants.
2. Seroepidemiology of PPR in domestic small  rum inants in Tanzania w th or without wild-
life contact.
The filter paper evaluation will use current scientific advances as groundwork to improve the 
transportation and analysis of whole blood samples. This possible improvement is performed 
through applying the method of ELISA analysis of filter paper samples compared to serum 
samples. By fine-tuning the interpretation of these results, the goal is to suggest a practical and 
functional alternative to serum samples as transport medium. 
By participating in this project I was hoping to learn more about epidemiology in general and 
particularly the epidemiology of PPR, a disease that is not currently present in Sweden. As a 
benefit for me and for my future professional life as veterinarian, my laboratory skills were 
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improved through this project. By travelling to Tanzania I also broadened my way of thinking 
and learned more about disease control on a global scale. Through living and working in an 
unfamiliar country, I learned the importance of cultural and religious differences. This type of 
understanding in general is of utter importance for international networking and is fundamental 
to trans-national epidemiologic research.  
3 
2 Literature review 
2.1 Peste des petits ruminants virus 
PPRV is currently considered one of the main animal transboundary diseases that constitutes a 
threat to livestock production in many parts of the world, particularly developing countries 
across Africa, the Middle East and south Asia (Banyard et al., 2010). PPRV is currently present 
in West, East and Central Africa, Arabia, the Middle East and southern Asia (Karimuribo, 2011; 
Nanda et al., 1996; Shaila et al., 1996). According to FAO, roughly 80% of the world’s total 
population of sheep and goats is considered to be at risk of infection with PPRV (FAO, 2015b). 
2.1.1 Genetic properties and taxonomy 
PPRV is a negative single strand RNA virus belonging to the genus Morbillivirus, sub-family 
Paramyxovirinae and family Paramyxoviridae. It is closely related to Measles virus (MV) 
(Brown et al.), Rinderpest virus (RPV) and Canine distemper virus (CDV) amongst others.  
Although PPRV is sometimes referred to as an emerging virus, having only been recognized as 
a distinct viral entity since 1979 (Gibbs et al., 1979). The PPRV branch from the supposed 
common predecessor of the morbilliviruses is at least as long as those presenting the evolution-
ary distance of MV and RPV from their point of separation (Gibbs et al., 1979). Given that MV 
is believed to have separated from this common ancestor at least 1,000 years ago (Furuse et al., 
2010), it would seem that PPRV has been with us for many hundreds of years, unrecognized as 
a virus until the development of molecular methods to distinguish it from RPV. 
Figure 1, Schematic structure of the PPR virion (Herbe 2015) 
2.1.2 Life cycle and survival 
The PPRV enters the and attaches to host cell membrane receptors. This binding is mediated 
by a haemagglutininneuramidase (HN) protein and the sialic acid on the host cell membrane 
anchored receptors (Munir et al., 2013). The interaction proceeds with the fusion protein (F) 
allowing fusion of the virion envelope with cellular membranes (Chauhan et al., 2009). The 
virus becomes uncoated and the nucleocapsid (N) is eventually released into the cytosol of the 
infected cell through endocytosis. Replication of the viral RNA takes place in the cytosol and 
results in full-length, positive stranded anti-genomes as well as a number of mRNAs. The full-
length anti-genomes are transcribed into copies of the negative-stranded virus genome. Further-
more, translation of viral proteins takes place in the endoplasmic reticulum and the cytoplasm. 
All structural and non-structural proteins self-assemble with the genomes near the cell surface 
whereas the budding process begins, resulting in the release of functional virions (Munir et al., 
2013).  
2.1.3 Lineages 
There are one serotype of PPRV, nonetheless there are clear lineages based on phylogenetic 
analysis of the virus genes, more specifically the N or F genes (Baron et al., 2011). PPRV can 
be divided into four different lineages: I, II, III and IV.  Historically, viruses of lineages I and 
II have been identified in West Africa. Lineage III have been found in East Africa and Arabia, 
in countries as Sudan, Yemen and Oman. Lineage III has also been identified in southern India, 
though only at one occasion. Historically, lineage IV has been found in the Middle East and the 
Asian subcontinent (Banyard et al., 2010; 'Dhar et al., 2002). However, lineage IV has been 
found circulating all across the PPR endemic areas (Parida et al., 2015; Libeau et al., 2014). 
The utility of lineage identification lies in the information it provides regarding the probable 
origin of the virus causing the outbreak. PPRV lineage identification showed for example that 
an outbreak in Morocco in 2008, which was the first time the virus had been seen in North 
Africa, was a lineage IV virus. Since the virus was of this lineage it therefore had not come 
from West Africa, in which all viruses are of lineages I or II. Instead this virus was likely to 
have been introduced from the Middle East, where PPRV of lineage IV circulates (Baron et al., 
2011). This type of genetic data is routinely used to construct phylogenetic trees for PPR and 
attribute different isolates to each of the four lineages (Banyard et al., 2010; 'Dhar et al., 2002). 
Though the characterization of viruses into lineages is important to epidemiological studies, it 
appears unlikely that this lineage differentiation has a relationship to virulence of isolates. The 
differentiation is rather a result of geographical speciation (Munir, 2015). 
Phylogenic analysis of nucleoprotein and fusion genes have been made on samples isolated 
from wild ungulates. The result of these analyses indicates that strains identified from PPRV 
infection in wild ungulates have historically been exclusively from lineage IV (Munir, 2014). 
This was the case until recently, when lineage II was identified in wild ruminants near domestic 
livestock in northern Tanzania (Mahapatra et al., 2015). 
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2.1.4 Occurrence and history 
PPR was first described 1942 on the Ivory Coast as a disease of its own. As a sickness of sheep 
and goat it had formerly been recorded as Bluetongue amongst other diseases (Gargadennec & 
Lalanne, 1942). Moreover, because of the clinical similarities and the classical course of the 
disease, PPRV was long thought to be a variant of RPV that had become adapted to small 
ruminants and lost its virulence for cattle (Banyard et al., 2010; Gibbs et al., 1979). It is likely 
that early cases of RP described in sheep and goat actually were PPR (Baron et al., 2011). 
Because of this common misconception we do not know the true origin of PPRV or how long 
it has been circulating in different parts of the world. PPR has only been recognized as a com-
pletely distinct disease in the past 40 years when Gibbs et al., proved in 1979 the PPRV to be a 
member of the genus Morbillivirus.  
Since its first discovery, PPR has spread through sub-Saharan Africa, the Middle East, Turkey 
as well as the Indian subcontinent. Until 1979 PPR was described mostly in West African coun-
tries after which it emerged in Eastern and Northern Africa as well. In the last few years, the 
first outbreaks of PPR have occurred in China, in East Africa, and in North Africa (Munir et 
al., 2012). The transboundary spread of PPR is suggested to be exacerbated by the development 
of trade relations, tourism, transport and migration of wild animals (Kaukarbayevich, 2009). 
The disease is currently present in Central, Eastern and Western Africa, Asia, and the Middle 
East (Banyard et al., 2010). Today, a total of 76 countries have officially confirmed PPR within 
their borders. The regions in which these countries are situated is the home to approximately 
1.7 billion heads, roughly 80 percent, of the worlds total population of sheep and goat (FAO, 
2015b).  
2.1.5 Hosts and transmission 
The main hosts for PPRV are goats and sheep of both sexes and all ages. Other ruminants like 
cattle, buffaloes and wild small ungulates, as well as camels and pigs, may be infected 
(Abraham et al., 2005). In poor conditions cattle can show signs of infection similar to RP when 
infected with PPRV (Kwiatek et al., 2011; Diallo et al., 2007). Though other species than small 
ruminants like cattle might get infected, there is at this time no evidence that unusual hosts like 
cattle, buffaloes or camels have a significant role in the transmission of PPRV (OIE, 2015a). A 
study from 2008 suggests that the prevalence of PPRV infection is higher in animals older than 
two year relative to younger animals. Furthermore, there is a correlation between gender and 
infection with PPRV where females tend to be infected to a greater extent than male sheep and 
goat (Khan et al., 2008). Additionaly, findings following experimental infection with PPRV 
suggest that sheep display milder clinical disease compared to goats (Truong et al., 2014).  
Transmission of PPRV from infected animals occurs via discharges from eyes, nose and mouth, 
as well as diarrhea or loose faeces. All of these excretions contain high titers of virus and trans-
mission usually occurs through an aerosol over very short distances. Moreover, except for close 
contact, which remains the most frequent means of disease transmission, additional routes of 
transmission may be contaminated water, feed troughs and bedding. Virus does not survive for 
long outside the host, therefore most transmission occurs during the febrile, acute clinical stage 
of disease (Braide, 1981). 
Wildlife 
Wild ruminants may play an important epidemiological role as source for PPRV in domestic 
small ruminants (Kinne et al., 2010). Antelope and other small wild ruminant species can be 
severely affected (Adel et al., 2004). Clinical disease has been reported in wildlife resulting in 
deaths of gazelles and Sindh ibex (Abubakar et al., 2011). The American white tailed deer can 
be infected experimentally with possible fatal consequences (Hamdy & Dardiri, 1976), though 
natural infection with PPRV have not been observed on the American continent.  
It is crucial to further evaluate the role of wildlife in the epidemiology of PPR. Since domestic 
and wild ruminants intermingle in many areas, inter-species transmission of PPRV is possible. 
This might interfere with current disease surveillance and eradication programs but might as 
well be a serious threat to the survival of endangered wildlife species (Munir, 2014). One hy-
pothesis is that PPRV infection in wild animals is not self-sustained and therefore cannot sur-
vive within the wild population itself. Instead it is suggested that infection among wildlife is 
the result of PPRV spread by domestic small ruminants neighboring natural parks (spill-over) 
(Couacy-Hymann et al., 2005). To conclude, the wildlife host range of PPRV needs additional 
research and is not yet fully understood. There is at this time no reason to believe that PPRV 
circulates in wild animals and thereby acts as a possible source of virus for domestic species 
(Munir, 2014).   
2.1.6 Pathogenesis 
At experimental infection through intranasal route it is suggested that immune cells within the 
respiratory mucosa absorb the PPR virus. The immune cells then transport virus to lymphoid 
tissue, from where primary virus replication occurs. Virus subsequently enters the circulation 
for continued systemic infection. It is hence believed that the initial reproduction of virus in-
stead of being performed within the epithelial cells of the respiratory mucosa, is in the nearest 
draining lymphoid tissue (Pope et al., 2013). Moreover, an evaluation of tissue tropism at PPRV 
infection showed that lymph nodes, lymphoid tissue and digestive tract organs are the predom-
inant sites of PPRV replication (Truong et al., 2014). As infection progresses, leucopoenia, 
lymphopoenia and a suppressed antibody response may be observed. It also results in an in-
creased risk of activating latent infections, for example intestinal and blood parasites, which 
increase the perceived mortality rate of PPR (Taylor, 2005). Upon infection with PPRV, both 
sheep and goat develop clinical signs though sheep tend to display a milder clinical presentation 
compared to goats (Truong et al., 2014). Some clinical signs presented at infection, particularly 
respiratory disease, derive from secondary infection as a result of the immunosuppressive effect 
from PPRV (Baron et al., 2011).  
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2.1.7 Clinical picture and pathology 
The clinical presentation of PPR is divided into three categories: Acute, peracute and subacute 
form. As the acute form often presents sudden pyrexia and a gradual exacerbation of clinical 
signs that may result in death, the peracute form presents a severe pyrexia, depression and 
higher mortality (OIE, 2016). The subacute form may result in inconsistent clinical signs for 
10-15 days. Incubation time for PPR is usually 4–6 days, but can range between 3 and 10 days.
The clinical phase of the acute form presents pyrexia up to 41°C that can last for 3–5 days (OIE,
2016).
Affected animals become anorectic, depressed, and develop a dry muzzle. Oculonasal dis-
charges gradually become mucopurulent (Figure 2) and persist for up to 14 days, though death 
may already have ensued by then. Gums eventually become hyperemic, and erosive lesions 
with or without necrosis develop in the oral cavity combined with excessive salivation. Diarrhea 
is common in the later stage, often watery and bloodstained (Abubakar et al., 2008). Pneumo-
nia, coughing, and abdominal breathing also occur. The morbidity rate can reach up to 100% 
with a high case fatality rate in severe cases. Morbidity and case fatality may however be low 
in mild outbreaks and the disease may therefore be overlooked (OIE, 2015a). While case fatality 
rates in naïve herds have reportedly reached up to 90%, in endemic areas the fatality may drop 
as low as 20% (Chauhan et al., 2009). 
At necropsy, findings include crusty scabs along the outer lips and severe interstitial pneumonia 
is frequently presented (Chauhan et al., 2009). Erosive lesions may extend from the mouth via 
esophagus to the reticulorumen junction. Erosive or hemorrhagic enteritis is generally present 
and the ileo-caecal junction is often involved. Peyer’s patches can also be necrotic. Enlarged 
Figure 2, Sheep with sings of mucopurulent nasal discharge in the Mahenge area. (Photo: Nils Roos) 
 
lymph nodes and necrotic lesions may be observed in the spleen and liver (OIE, 2015a). Find-
ings suggest that infection with PPRV also is associated with abortion in goat (Abubakar et al., 
2008).   
2.1.8 Diagnosis 
Acute infection with PPRV can often be diagnosed through its clinical signs. A number of dis-
eases is clinically similar but may be excluded in the case of PPR from its significant differ-
ences. Some of these diseases are foot and mouth disease, bluetongue, sheep-/goat pox, conta-
gious caprine pleuropneumonia and pneumonic pasturellosis. These are all diseases that may 
be found circulating in areas with PPR and have similar presentations. Though differential di-
agnoses often can be excluded it may however be difficult to distinguish them from PPR if the 
clinical presentation is mild or secondary infections have occurred (Baron et al., 2011). When 
diagnosing mild PPR, it is therefore necessary to use laboratory methods to confirm the disease. 
The two general approaches to this confirmation are firstly to search for the PPR virus traces 
like antibodies directed against the nucleocapsid (N) protein through immunocapture ELISA or 
virus nucleic acids through PCR. Both of these methods are used to detect acute infection. Sec-
ondly, another approach is to search for antibodies induced by PPRV infection through com-
petitive ELISA (c-ELISA), a method commonly used in surveillance studies to map out the 
spread of the disease (Libeau et al., 1994; Libeau & Lefevre, 1990). 
2.1.9 Impact on poverty and economics 
The economic incentive for PPR control and/or eradication has been a major subject for discus-
sion in the past.  Current epidemiology, low individual economic value of hosts (i.e. sheep and 
goat) and high turnover in herds has made accurate cost/benefit-calculations difficult to achieve 
(Baron et al., 2011). Since few recent studies have been able to estimate the economic losses 
caused by PPR, the complete and comprehensive economic impact of PPR on small ruminants 
is currently not known (Munir, 2015). Though there is a discussion of the exact severity of the 
economical impact of the disease, there is no doubt that losses caused by PPR strike at the heart 
of vulnerable livelihoods. Countries have experienced accumulative yearly losses varying from 
tens to hundreds of millions of US dollars (The Global Strategy for the Control and Eradication 
of PPR, 2015).  
Though the economical calculations are problematic, there are a number of studies on the esti-
mated cost of PPRV infection (Kaukarbayevich, 2009; Hussain et al., 2008; Opasina & Putt, 
1985), some of which suggest that the lowest costing preventive measure of controlling PPR 
outbreaks could be timely vaccinations (Thombare & Sinha, 2009).  
2.1.10  Eradication strategy 
In the eradication strategy of PPR there are a number of aspects that needs to be addressed. 
Often when eradication of PPR is discussed, parallels are drawn to the strategic eradication of 
RPV (Munir, 2015). Since the two pathogens have fundamental antigenic and immunological 
similarities, this is appropriate. A lot can be learned from the way RPV was eradicated but there 
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is many factors in which PPR differ from RP. This needs to be considered. For instance, species 
infected by PPRV like sheep and goat have a considerable higher reproduction rate and turnover 
compared to species generally infected by RPV like cattle (Munir, 2015). This makes the in-
fection rate faster and complicates control of the disease status of a herd. Also, the duration of 
immunity following an infection with RPV is lifelong contrary to infection with PPRV which 
is 3 years (Munir, 2015). Furthermore, while the host spectrum with ability to carry RPV for 
further infection was limited to domesticated animals, spread of PPRV through for example 
wildlife is still uncertain (Baron et al., 2011). Additionally, with the eradication of RPV and 
vaccination against this disease have ceased, infection with PPRV is found to increase as a 
result. This is not only because of the cross-protective effect of RPV vaccination against PPRV, 
but also because many disease cases, which before were discarded as variations of RPV infec-
tion, are now correctly labeled as PPR. Hence the disease might appear to be emerging in greater 
extent than it actually is (Munir, 2015; Baron et al., 2011). Also, the absence of RPV implicates 
that small ruminants no longer can get infected and thereby gain cross-immunity against PPRV. 
The infection rate of PPRV may thereby increase (Baron et al., 2011). 
FAO and the OIE convened in the spring of 2015 and are together mobilizing the international 
community around the fight against PPR. At the conference, FAO and OIE launched the global 
campaign to eradicate the disease by 2030. The campaign concentrates on areas in Asia, the 
Middle East and Africa affected by the disease. The two organizations hope to lead and coor-
dinate global efforts of governments, regional organizations, research institutions, funding part-
ners and livestock owners to eradicate PPR (FAO, 2015b). The conditions to achieve this global 
control and eradication by 2030 is to adequately distribute and coordinate resources at all levels. 
Furthermore it is important that this strategy is supported by all cooperating partners (The 
Global Strategy for the Control and Eradication of PPR, 2015).  
2.1.11 Vaccines 
Live attenuated homologous non thermo-stable PPR vaccines have been available on the market 
for some time. They contain a range of PPRV isolates, for example Nigeria 75/1 and Shun-
gri/96, which have been attenuated through serial passages in Vero cells (Saravanan et al., 
2010). The vaccines have been proven to be highly effective and are suggested to provide life-
long immunity in both sheep and goats. These successful vaccines are used in many PPRV 
endemic countries (Munir et al., 2012). Though there are at this point no working PPRV vaccine 
making it possible to serologically distinguish vaccinated animals from infected ones, a so-
called DIVA vaccine (Munir, 2015).  
2.2 Tanzania 
Tanzania is a country in East Africa with 26 different regions and a population of almost 51 
million people. On an area of 945 203 km2 (Landguiden, 2015; FAO, 2015a), the country is 
famous for its rich nature and diverse wildlife. While tourism is calculated to generate 22.9% 
of the annual income, agriculture is the most important sector and is estimated to be 26% of the 
gross domestic products. Morogoro, which is the name of the city as well as the region, is also 
the centre for agricultural sciences in Tanzania (Landguiden, 2015). Most of research around 
PPR in Tanzania is performed at the Sokoine University of Agriculture (SUA) in Morogoro.   
2.2.1 Peste des petits ruminants in Tanzania 
PPR has been found in several regions of Tanzania over the last decade (Muse et al., 2012; 
Swai et al., 2009). The first outbreak of PPR in Tanzania was confirmed in the northern region 
in 2008. It was supposedly introduced from neighboring countries in the north (Swai et al., 
2009). A study made in the southern part of Tanzania on the occurrence of PPR infection in 
sheep and goat confirmed the spread of PPR since 2009 and showed a seroprevalence of 31% 
in tested animals (Muse et al., 2012).  
There are suspicions that PPR outbreaks occurred in Tanzania long before 2008. A study based 
on reports from livestock field officers and District Veterinary Officer suggest that PPR was 
present in northern Tanzania at least four years before the official confirmation (Karimuribo, 
2011). PPRV was yet again detected in the south of Tanzania in 2010 (Muse et al., 2012). 
Samples collected in 2012-2013 from the northern and eastern parts of Tanzania also confirmed 
active PPRV-infections (Kgotlele et al., 2014). This indicates that there is an on-going spread 
of the disease. There is since 2009 evidence of natural transmission of PPR and circulation of 
the virus within domestic herds (Swai et al., 2009). There has been an apparent risk that PPR 
may continue to spread southward across and beyond the Tanzanian border (Muse et al., 2012). 
The reality of this risk is emphasized as Karimuribo et. al., point out how the governmental 
apparatus in Tanzania is somewhat limited in surveillance, reporting and control of transbound-
ary diseases (Karimuribo, 2011). Today, we know that PPR is continuing to spread across the 
Tanzanian border and that subclinical infection with PPRV has been discovered in Zambia 
(OIE, 2015b). 
2.2.2 Prevention and vaccination 
Tanzania has been the southern border of PPR and Chazya et al. concluded in 2014 that the 
overall risk of PPRV spreading to northern Zambia could be considered as high (Chazya et al., 
2014; Muse et al., 2012). As a result of this risk, an emergency vaccination program were 
launched and implemented in the northern half of Tanzania in 2010 (Munir et al., 2012). In 
September of 2011, a vaccination campaign with a focus on small ruminants along livestock 
marketing routes was implemented (OIE, 2012). Furthermore, due to mandatory vaccination 
campaigns most herds in the area around Mikumi National park (central and eastern part of 
Tanzania) were vaccinated in late spring of 2013 (Herbe, 2015). Despite the ambition of the 
vaccination program, the effect varied. For example, coverage of the vaccinations was only 
32% in northern parts of Tanzania. This suggests continued prevalence of the disease in certain 
areas (Karimuribo, 2011). In May 2015 antibodies against PPRV was found in Zambia on four 
separate occasions (OIE, 2015b). 
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2.3 Filter paper as sample transport medium 
In many developing countries, the diagnosis and genotyping of PPRV may be hampered by 
inadequate infrastructures and by lack of proper laboratory facilities. Samples with potential 
fragile virions risk being spoiled during transport with an insufficient cold chain from the field 
to laboratories (Bhuiyan et al., 2014). This suggests that a sample medium that sustains the PPR 
virion or its corresponding antibodies without the need for a cold chain thereby improves the 
method of detecting PPRV infections in areas with insufficient infrastructures. Filter paper sam-
ples may be a potential solution to this issue (Punnarugsa & Mungmee, 1991). 
2.3.1 Nobuto filter paper strips 
Several studies have been made where Nobuto filter paper (FP) has been used as a transport 
medium with both serum and whole blood for detection of an agent or antibodies from infection. 
Already in 1974 a study by Wolff and Hudson investigated the value of Nobutos' FP in sero-
logical studies. Here the method showed difficulties of detecting samples with low titers. In 
spite of this, the advantages of FP was considered and said to counterbalance this issue. Some 
of the advantages was said to be the simple method of sample collection and handling, minimal 
personnel training, and the low amount of blood required (Wolff & Hudson, 1974).  
In 2011 Curry et al., showed how detection of Brucella spp. in caribou through c-ELISA could 
be used to compare blood-saturated Nobuto FP strips to serum samples. To evaluate FP perfor-
mance, serum sample results were used as gold standard. The result showed a difference in 
prevalence from Brucella spp. with FP at a sensitivity of 89% (95% CI: 82-95%) and specificity 
of 99% (95% CI: 97-100%) compared to the serum sample gold standard. This trial also showed 
how dried FP blood samples from caribou stored for two months in room temperature were 
comparable with serum for use in Brucella spp. c-ELISA (Curry et al., 2011). The Nobuto FP 
was furthermore evaluated by Curry et al., in a study published 2014 where whole blood eluded 
FP was compared to serum for detecting antibodies from a number of pathogens in reindeer and 
caribou. Two of these pathogens, Neospora caninum and West Nile virus (WNV), were ana-
lyzed through c-ELISA. The FP analysis resulted in a specificity of 92% (95% CI: 61.5-99.8) 
for both pathogens and a sensitivity of 98% (95% CI: 91.3-100.0) for Neospora caninum and 
95% (95% CI: 80.7-100.0) for WNV. This trial also showed that in case of insufficient sensi-
tivity from FP samples, lowering the threshold to raise sensitivity could compensate this issue 
without thereby lowering the specificity notably (Curry et al., 2014). 
The Nobuto FP was also evaluated 2011 in a trial by Dusek et al., investigating the detec-
tion of avian influenza antibodies in mallards (Anas platyrhynchos). The mallards were exper-
imentally infected with low pathogenic avian influenza viruses and later on bled with subse-
quent serological analysis of both serum and FP. FP samples proved to reliably detect positive 
and negative samples, which prompted the verdict: “Nobuto strips are a convenient and sensi-
tive alternative to the collection of serum samples when maintaining appropriate storage tem-
peratures is difficult” (Dusek et al., 2011). 
2.3.2 Sartorius 3MM filter paper sheets 
It has been shown in previous studies that Whatman® 3MM FP (GE Healthcare, France) pre-
serves nucleic acid sufficiently for subsequent diagnostic analysis. The nucleic acid of PPRV 
has been shown to be preserved in FP for at least 3 months at 32°C (Bhuiyan et al., 2014). 
The 3MM FP is a chromatography paper made of 100% cotton linters with an alpha-cellulose 
content of more than 98%. This FP from Sartorius is delivered in sheets ready to be cut in 
suitable shapes and sizes. The use of this type of paper are not only limited to chromatography 
but can also be used for a wide range of absorption applications (Sartorius). 
In a trial from 2014 by Randriamparany et al., the Sartorius 3MM FP was used to detect anti-
bodies against African Swine Fever (ASF). Blood samples on FPs and serum samples were 
drawn from experimentally infected pigs, farm pigs in Madagascar and from Côte d´Ivoire. The 
study showed that the Sartorius FP was successful in preserving antibodies against African 
Swine Fever virus (ASFV) from blood-dried samples through ELISA analysis 
(Randriamparany et al., 2014). The sensitivity was very close to conventional analysis on serum 
samples and can therefore be considered as being an alternative to serum in this type of study 
(Randriamparany et al., 2014). 
Several studies have demonstrated that the use of Whatman FP and other types of 3MM FP as 
an alternative transport medium for blood samples with the purpose of detecting virus infections 
(Punnarugsa & Mungmee, 1991). 
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3 Material and methods 
3.1 Study area and study design 
The data collection was performed in three different areas in the Morogoro region. Two of these 
areas were in the Kilombero district and the third area was situated in the Ulanga district. Areas 
were chosen together with assistant supervisor Emeli Torsson, local supervisor Dr. Gerald Mis-
inzo and local extension officers. Data collections took place during two field trips in June and 
July 2015 and were located to two districts in the Morogoro region. During the first field trip 
samples were collected in the Mikumi region, while during the second trip in the regions of 
Ulanga and Kilombero.  
Figure 3. Tanzania, Morogoro district marked in Yellow. (Nils Roos) 
14 
In these three areas, samples were obtained from goats and sheep belonging to both Maasai 
pastoralists and traditional farmers. Blood samples, nasal swabs, rectal temperature, observa-
tion of clinical signs and in some cases blood saturated FPs were collected from each animal. 
FP samples were collected only when allowed due to time, staff and workload issues. Goats 
and sheep of both sexes were sampled and the selection was focused to animals older than three 
months since younger animals could still hold maternal antibodies, and animals younger than 
one year were chosen to ensure correct vaccination status according to the owner. If possible, 
animals with clinical signs in concordance with PPR were selected.  In total, 468 animals from 
46 herds in 15 different villages were sampled. All areas had various amounts of interaction 
between wild grazing animals and domestic small ruminants. The farmers practiced communal 
grazing systems for their sheep and goats. In some areas, the animals more or less grazed side 
by side with the wild population of ruminants. In some areas the domesticated animals came in 
contact with wild ruminants only during dry season. 
3.1.1 Questionnaire 
All herd owners were interviewed before sample collection, according to a premade question-
naire. The interview was performed with a translator, usually the assistant extension officer. 
The questionnaire was designed to focus on health, vaccination and deworming status, flock 
size, contact with other animals, sex and approximate age of each animal. There was also a 
section about the last presumed PPR outbreak, and what the detailed effects on the flock were 
in terms of affected animals, deaths and abortions (see table below). The questionnaire con-
tained the following questions:  
• How often do animals come in contact with other domestic herds?
Figure 4. Morogoro district of Tanzania, sample areas in red. (Nils Roos) 
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• How often do animals come in contact with wildlife?
• Latest introduction of new animals to herd
• Last vaccination of herd against PPR….… CCPP……. FMD……. 
• Last de-worming treatment of herd………….. all animals treated? 
• Last antibiotic treatment of herd……………. all animals treated? 
• Estimated date when first PPR case was observed at this farm
• Detail of animals
• Type of farming: [  ] Household, [  ] dairy production, [  ] meat production ,   [  ] individual
seller at live animal market, [  ] others (please specify)
• Clinical signs at outbreak: [  ] Abortion, [  ] Diarrhea, [  ] Pneumonia, [  ] Oral mucosal
lesions, [  ] Nasal and ocular discharges, [  ] High temperature
• Other signs or comments
Table 1. The “details of animals” part of the questionnaire given to the farmers 
Age group <1 year >1 year
Total Affected Died Aborted Total Affected Died 
Sheep 
Goat 
3.2 Data collection 
Animals were bled from the jugular vein into serum tubes using a vacutainer system. Occasion-
ally, when animals with signs of infection in concordance with PPR were encountered, EDTA 
blood tubes were also used. All tubes were placed in an upright position and in a cooler box 
before transported back to the laboratory. Later, all tubes were centrifuged to allow serum sep-
aration from clotted blood samples. The serum, buffy-coat and plasma were decanted and ali-
quoted into cryotubes marked with a number for each individual animal. Samples were trans-
ported to the laboratory at SUA, Morogoro for analysis. All samples were labeled accordingly 
so each animal and flock could be identified. Up to three different nasal swabs were taken of 
the sampled animals: 
• A damp cotton-tipped swab to apply the content on FTA-cards for later PCR analysis.
• Copan Innovation’s Advanced flocked swab was used on each animal for storage and later
purification of RNA in the local laboratory.
• A nasal e-swab was occasionally used, mainly on individuals with clinical signs correspond-
ing to PPR. These swabs were stored for later purification of DNA and transported to Brazil
for analysis for presence of Mycoplasma.
Age, sex and breed of each animal were recorded. To determine the sample size in the sero-
prevalence study at least 270 samples from small ruminants would need to be included. This 
sample size would be enough to estimate the prevalence with a precision of 5% and a confidence 
interval of 95%.  
3.3 Laboratory analysis 
Serum samples were analyzed with a competitive enzyme-linked immunosorbent assay 
(cELISA) from ID.Vet Innovative Diagnostics, identifying levels of antibodies directed against 
the nucleoprotein of PPRV. The cELISA has a high diagnostic specificity (99.4%) and sensi-
tivity (94.5%) for detection of PPRV antibodies in serum (Libeau et al., 1995). All analyses 
were made from serum that had been decanted from serum tubes into cryotubes, frozen to -
45°C and later thawed for analysis.  
3.3.1 PPRV competitive ELISA 
The microplates in the cELISA-kit had 96-wells coated with purified recombinant PPR nucle-
oprotein. To each plate, 92 serum samples were added together with two positive and two neg-
ative controls. With an added sample, existing antibodies in the sample formed a complex with 
the antigen thus masking the nucleoprotein epitopes. A peroxidase-conjugated anti-nucleopro-
tein antibody was then added to the wells, forming a complex with the remaining nucleopro-
teins. Subsequent washing and adding of the substrate solution caused a coloration to appear 
depending on the amount of antibodies in the original sample. The magnitude of the color yel-
low in each well indicated the correlating absence of antibodies in the original sample. No yel-
low coloration indicated the presence of antibodies in the original sample. Immediately after 
adding of the substrate solution the 96-well microplates were analyzed at 450 nm in the micro-
plate reader. The result of this analysis was presented in an optical density of each well.  
The validation of each microplate was performed through calculating the mean optical density 
of the negative and positive controls. If the mean value of the negative controls were greater 
than 0.7 and the mean value of the positive controls less than 30% of the optical density of the 
negative control, the analyses were valid. Each optical density from the 92 remaining wells was 
subsequently compared to the mean optical density of the negative controls with this mathe-
matical formula: 
S/N% = (Sample optical density / mean negative control optical density) x100 
Samples with S/N% values less than or equal to 50% were considered positive (P) and samples 
with S/N% values greater than 60% were considered negative (N). Samples in between 50% 
and 60% were considered doubtful (D).  
Filter paper use in blood sampling 
Two kinds of FP were used in this study. The first type, Advantec Nobutos' FP strips is a precut 
blood sampling paper developed for serological reactions. The Sartorius FP was delivered in 
sheets of a thinner kind of paper that could be cut to fit the needs of the situation. The sheeted 
FP was cut to a similar size as the Nobuto strips, circa 10x50mm. In that way both types of FP 
could be placed in the “Nobuto filter strip drying rack” designed for Nobuto strips.  
In the field, FP were used in parallel to vacutainers in order to collect blood samples from goats 
and sheep. Blood was absorbed to the filter strips through dipping the FP in blood-filled serum 
vacutainer tubes enough to saturate the narrow area of the Nobuto filter strips. To the second 
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type of FP, blood was absorbed to an area larger or equal to the narrow area of the Nobuto filter 
strips.  
Both types of FP were placed in the drying rack. The filter papers were placed with enough 
distance to avoid for them to stick to each other. Blood-absorbed FPs were put in room temper-
ature away from direct sunlight for at least 24 hours to dry. Dried FPs were stored in boxes, 
kept away from liquids and moist.  
Filter paper use in laboratory analysis 
Dried FP were cut with cleaned scissors into 75mm2 pieces, which corresponds to half of the 
narrow area of the Nobuto filter strips. Each 75mm2 piece was then cut into 5-8 smaller pieces 
and placed into a 1.5ml eppendorf tube. Each eppendorf tube was finger-flicked to make sure 
the pieces of FP rested in the bottom of the eppendorf tube.  
The eppendorf tubes were marked with its corresponding sample ID number. Each tube was 
thereafter filled with 150μl Dilution Buffer 13 from IDvets cELISA PPR-kit. Filter papers were 
allowed to elude in room temperature for 60 minutes according to the Nobuto FP manufac-
turer’s instructions. At the start and end of the incubation period each tube was vortexed for a 
few seconds to ensure that all pieces of FP came in contact with the solution and that the solution 
was homogenized. A volume of 50μl eluate was transferred to its corresponding test well in the 
Figure 5. Filter paper, an alternative way to collect blood samples in field conditions. Photo Nils Roos 
ELISA plate. The eluate was at this point diluted to approximately 2:15. This dilution was used 
as the only element in the ELISA wells prior to incubation.  
The cELISA was otherwise performed according to manufacturers instruction (see 3.3 Labora-
tory analysis), resulting in each sample ID being analyzed up to three times (serum sample, 
Nobuto filter paper (FP) sample and Sartorius FP sample). 
3.4 Calculating results, report writing and statistical analysis 
Data collection and results from ELISA analyses were obtained on site in Tanzania. Back in 
Sweden the results were analyzed and evaluated to assess the critical points relevant to this 
project.  
3.4.1 Statistical analysis 
Results from the laboratory analysis were evaluated with different statistical methods depend-
ing on the data being analyzed.  Statistical calculations were partly performed in the statistical 
software “Minitab” and partly performed by staff from the Unit of Applied Statistics and Math-
ematics, SLU. For the evaluation of PPR seroprevalence, a 95% confidence interval (CI) was 
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Figure 6. Filter paper drying and storage in the field. Photo Nils Roos 
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applied to the results. This resulted in a CI in which we could be 95% certain in the presence of 
antibodies from PPR infection in the sampled population. 
The evaluation of FP through ELISA as a diagnostic technique was analyzed with the statistical 
methods “Cohen’s Kappa” and “Weighted Cohens Kappa” (Cohen, 1968). These methods eval-
uate the level of agreement between results from serum and FP analysis for each sample.  
4 Results 
4.1 Serological prevalence of PPRV 
Table 2. Frequency of PPRV seroprevalence in sheep and goats based on serum analysis with optical density from cELISA. 
The cutoffs used were 50% for positive, 60% for negative and doubtful for those in between. 
Species Positive Doubtful Negative 
Sheep (n=158) 8.2% (n=13) 6.3% (n=10) 85.4% (n=135) 
Goat (n=323) 10.8% (n=35) 1.2% (n=4) 87.4% (n=284) 
Total (n=481) 10.0% (n=48) 2.9% (n=14) 87.1% (n=419) 
The table above shows the overall seroprevalence of PPRV in the sampled population. With a 
prevalence of 8.2% in sheep and 10.8% in goats, the total mean prevalence for both species 
comes down to 10.0%. A confidence interval (CI) of 95% for the total prevalence gives the 
span of 7.4% to 13%. This, though, cannot be considered as the true seroprevalence since vac-
cinated animals represent some of the positive results. Since there is no DIVA vaccine available 
and it thereby is impossible to distinguish a previously infected animal from a vaccinated one, 
this has to be taken into account. By re-doing the calculation and disregarding all vaccinated 
animals and animals older and younger than 3 to 12 months, we hoped to reach a seroprevalence 
closer to the truth.  
Table 3. Frequency of positive, doubtful and negative samples from non-vaccinated goats and sheep of ages 3-12 months based 
on cELISA serum analysis with optical density cutoffs at 50% for positive, 60% for, negative and doubtful in-between. 
Species Positive Doubtful Negative 
Sheep (n=93) 4.3% (n=4) 6.5% (n=6) 89.2% (n=83) 
Goat (n=183) 2.7% (n=5) 1.1% (n=2) 95.6% (n=175) 
Total (n=276) 3.3% (n=9) 2.9% (n=8) 93.5% (n=258) 
From the table above we can see that disregarding animals with a positive or unknown vaccina-
tion status and at the same time only calculating the seroprevalence in animals 3-12 months of 
age gives a total seroprevalence of 3.3% (n=9; CI 3.2-6.1%).  
To give insight into the possible aspect if the disease could spread to and/or from wildlife, one 
of the questions in the questionnaire given to the farmers regarded contact with wildlife. On the 
question “How often do animals come in contact with wildlife?” some farmers answered vari-
ations of “Every day” or “Yes” (n=16). While some answered variations of “No” (n=23), others 
did not answer at all (n=7). The absence of answers to this question might be lost in translation 
or be because the farmers themselves are uncertain on the herds contact with wildlife.  
Table 4.  Frequency of positive, doubtful and negative samples from non-vaccinated animals of ages 3-12 months with differ-
entiation between animals with and without wildlife contact, based on cELISA serum analysis with optical density cutoffs at 
50% for positive, 60% for, negative and doubtful in-between. 
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Wildlife contact Positive Doubtful Negative 
Yes (n=95) 1.1% (n=1) 2.1% (n=2) 95.8% (n=91) 
No (n=181) 4.4% (n=8) 3.3% (n=6) 92.3% (n=167) 
The seroprevalence in animals with wildlife contact, and stated criteria above, according to the 
questionnaire reached 1.1% (n=1; CI 0.03-5.73%). The seroprevalence in animals without wild-
life contact, and stated criteria above, reached 4.4% (n=8; CI 1.9-8.5%). 
4.2 Results from filter paper analysis 
To measure the performance of the two types of filter paper, optical density (OD) results from 
each FP sample was compared to the result from its corresponding serum sample. Figure 7 
illustrates to what extent the OD from positive FP samples follow the OD from corresponding 
serum samples. The specificity and sensitivity of the FP samples was also investigated through 
comparing them to their serum sample counterparts whilst changing the cutoff value for the 
positive, doubtful and negative labels.  
4.2.1 Filter paper absorbance level depending on whole blood or serum sample 
Positive samples on FP were compared between whole blood and serum in both types of filter 
paper. All positive FP samples were used in the comparison, a total of 21 samples. 
The graph (Figure 7) shows the disparity between the optical densities from the serum sample 
relative to the FP equivalents. A number of aspects in this graph is worth noting: Firstly, as the 
optical density of the serum sample increases to 30-50%, the values of the FP differ even more 
compared to the samples where the optical density is lower, at 20%. Note the cluster at sample 
ID 7, 16, 17, 18 & 19 compared to the scattered values at sample ID 1, 3, 4, 5, 8, 12, 20 & 21. 
Secondly, another aspect worth noting is the difference in optical density between the Nobuto 
and Sartorius filter paper. In close to every sample the Nobuto FP samples are following the 
serum samples to greater extent compared to the Sartorius filter paper. Thus the crucial aspect 
in mimicking the result of the serum sample results might firstly be to use a FP of high quality 
rather than using serum instead of whole blood as the eluding agent. Moreover, this graph only 
shows the positive samples and accordingly we cannot yet say anything about the specificity of 
the different filter papers. 
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Figure 7. Serum samples positive for PPR compared to correlating filter paper samples: Nobuto and Sartorius filter paper elu-
ate from either serum or whole blood (WB). Y-axis: OD percentage, X-axis: Sample ID. 
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4.2.2 Nobuto filter paper results 
Results from Nobuto FP OD compared to correlating serum sample OD. Sensitivity and speci-
ficity is monitored while cutoff values for FP OD is raised and thus changing the classification 
of some FP samples. 
Table 5. Correlation between results from serum sample analysis depending on different OD cutoff values regarding FP sam-
ples. 
Serum at 
50/60% cutoff 
Nobuto filter paper at 50/60% cutoff 
Positive Doubtful Negative Total % 
Positive (21) 11 2 8 10.5 
Doubtful (0) 0 0 0 0.0 
Negative (179) 0 1 178 89.5 
Total % 5.5 1.5 93.0 100 
60/70% cutoff 
Positive (21) 13 3 5 10.5 
Doubtful (0) 0 0 0 0.0 
Negative (179) 1 0 178 89.5 
Total % 7.0 1.5 91.5 100 
70/80% cutoff 
Positive (21) 16 2 3 10.5 
Doubtful (0) 0 0 0 0.0 
Negative (179) 1 1 177 89.5 
Total % 8.5 1.5 90.0 100 
80/90% cutoff 
Positive (21) 18 2 1 10.5 
Doubtful (0) 0 0 0 0.0 
Negative (179) 2 9 168 89.5 
Total % 10.0 5.5 84.5 100 
The purpose of Table 5 is to show the number of true results from FP samples in relation to the 
serum sample result depending on the change of cutoff value for the different classifications 
positive, doubtful and negative. The table above shows that by raising the OD cutoff value for 
“positive” and “doubtful” from 50 and 60 respectively to 60 and 70%, the number of true pos-
itive results compared to the serum results increases from 11 to 13. The number of doubtful FP 
results, however, increased from 2 to 3. The number of false negative results from the FP de-
creased from 8 to 5, at the same time the number of false positive increased from 0 to 1. In this 
fashion the FP sample classification change in relation to serum samples as the cutoff value is 
successively raised.  
4.2.3 Sartorius filter paper results 
Results from Sartorius FP OD were compared to correlating serum sample OD. Sensitivity and 
specificity was monitored while cutoff values for FP OD was raised and thus changing the 
sample classification as positive, doubtful and negative for some FP samples. 
Table 6. Correlation between results from serum sample analysis depending on different OD cutoff values regarding FP sam-
ples 
Serum at 
50/60% cutoff 
Sartorius filter paper at 50/60% cutoff 
Positive Doubtful Negative Total % 
Positive (21) 11 1 9 10.6 
Doubtful (1) 0 0 1 0.5 
Negative (176) 0 1 175 88.9 
Total % 5.6 1.0 93.4 100 
60/70% cutoff 
Positive (21) 12 2 7 10.6 
Doubtful (1) 0 0 1 0.5 
Negative (176) 1 0 175 88.9 
Total % 6.6 1.0 92.4 100.0 
70/80% cutoff 
Positive (21) 14 2 5 10.6 
Doubtful (1) 0 0 1 0.5 
Negative (176) 1 0 175 88.9 
Total % 7.6 1.0 91.4 100 
80/90% cutoff 
Positive (21) 16 3 2 10.6 
Doubtful (1) 0 1 0 0.5 
Negative (176) 1 7 168 88.9 
Total % 8.6 5.6 85.9 100 
The purpose of Table 6 is to show the number of true results from FP samples in relation to the 
serum sample result depending on the change of cutoff value for the different classification of 
positive, doubtful and negative. FP classifications change in relation to serum samples as the 
cutoff value is successively raised.  
4.2.4 Evaluating cutoff values for Nobuto and Sartorius filter paper 
To determine which cutoff value that is most suitable for each FP statistical calculations was 
made based on the disagreement between the serum results and the different filter papers. Two 
types of statistical methods were used: Cohen’s kappa coefficient, calculating the disagreement 
between FP and serum result; and the similar method Weighted Cohen’s kappa coefficient, with 
the addition of taking the level of disagreement into account. A 95% level confidence interval 
was included for both methods.  
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Table 7. Illustrating the correlation between serum sample results and different cutoff values for Nobuto FP and Sartorius FP 
with Cohen’s kappa coefficient and Weighted Cohen’s kappa coefficient with 95% confidence interval for both methods.  
Cutoff value Cohen’s 
kappa 
95% 
CI 
Weighted 
kappa 
95% 
CI 
Nobuto 50/60% 0.66 0.49 – 0.83 0.71 0.54 – 0.88 
Nobuto 60/70% 0.74 0.59 – 0.89 0.79 0.65 – 0.94 
Nobuto 70/80% 0.81 0.68 – 0.94 0.86 0.75 – 0.98 
Nobuto 80/90% 0.70 0.56 – 0.84 0.85 0.75 – 0.95 
Sartorius 50/60% 0.63 0.45 – 0.81 0.68 0.49 – 0.86 
Sartorius 60/70% 0.68 0.51 – 0.84 0.72 0.56 – 0.89 
Sartorius 70/80% 0.75 0.60 – 0.90 0.80 0.66 – 0.94 
Sartorius 80/90% 0.71 0.57 – 0.85 0.85 0.74 – 0.95 
The table above shows how the highest level of agreement between serum sample results and 
Nobuto FP is reached with a cutoff value of 70/80% with both Cohen’s kappa and Weighted 
Cohen’s kappa (coefficient value of 0.81 vs. 0.86). At this cutoff the confidence interval spans 
from 0.68-0.94 for Cohen’s kappa and from 0.75-0.98 for Weighted Cohen’s kappa.  
Simultaneously, the highest level of agreement between serum sample results and Sartorius FP 
is reached with a cutoff value of 70/80% using Cohen’s kappa at a value of 0.75 (CI 0.60-0.90) 
and 80/90% using Weighted Cohen’s kappa at a value of 0.85 (CI 0.74-0.95).  
To assess the significance of mentioned values above, an internationally recognized scale of 
measurement is used. The scale is rated as follows: 0-0.2 rated as “Poor”, 0.2-0.4 rated as “Fair”, 
0.4-0.6 rated as “Moderate”, 0.6-0.8 rated as “Substantial”, and 0.8-1 rated as “Good”. Conse-
quently, results from both Nobuto and Sartorius FP can be considered as “Good” at 70/80% and 
80/90% cutoff respectively, using the method of Weighted Cohen’s kappa coefficient. Using 
the confidence interval both FP methods ranges from being “Substantial” to “Good”.  
5 Discussion 
Total PPRV seroprevalence in present study, measured for both sheep and goat of ages 3-12 
months, results in a 3.3% (n=9; CI 3.2-6.1%) positivity for antibodies against PPRV in all three 
selected areas. This result is representative for animals between three months and one year of 
age. A seroprevalence of 3.3% is relatively low compared to earlier studies. Swai et al., showed 
a prevalence of 31% in southern Tanzania in 2009 (Swai et al., 2009). Furthermore, Herbe 
showed in 2015 a total seroprevalence of 16% in central and northern Tanzania, in animals 
older than 3 months. In the Mikumi area, the seroprevalence was as high as 21% (Herbe, 2015). 
Since Herbes result was obtained in central Tanzania it is geographically comparable to the 
present study. Hence, this could implicate a drop in seroprevalence of PPRV in central Tanzania 
under the time period between late 2014 and mid 2015.  
Though there are a number of additional recent epidemiological studies of PPRV in Tanzania, 
these studies focus on confirming ongoing spread of PPRV rather than its seroepidemiology 
(Munir, 2015; Kgotlele et al., 2014). It is therefore problematic to compare the results of present 
study to other epidemiological studies of PPR in Tanzania regarding the quantitative extent of 
the disease.  
The FP analysis shows that both Nobuto FP and Sartorius FP can be a viable alternative to 
serum samples in seroepidemiological screenings. It also shows good and substantial agreement 
between FP results, for both types of filter paper, and serum sample results when the cutoff 
value is raised. Though the present study concerns the previously not evaluated combination of 
PPRV as agent and FP as transport medium, there are a number of studies with a similar ap-
proach to the FP evaluation. Several studies establish that dried 3MM FP preserves antibodies, 
in serum or whole blood for later analysis, against a number of pathogens including Rubella 
virus and African swine fever virus (Randriamparany et al., 2014; Punnarugsa & Mungmee, 
1991). These results are in agreement with the 3MM analysis in the present study. Moreover, 
the present study correlates with earlier research in establishing that Nobuto FP preserves anti-
bodies in dried samples for later analysis. This is the case for analysis of antibodies against 
pathogens like Brucella spp., avian influenza, Neospora caninum and West Nile virus (Curry 
et al., 2014; Curry et al., 2011; Dusek et al., 2011). In concordance to the present study, Curry 
et al., also showed that adjusting the threshold of FP samples can lead to results comparable to 
serum samples (Curry et al., 2014). 
It can be argued that the chosen study areas from where samples were taken could be subject to 
biases in the way the areas were selected. Under optimal conditions, the areas would have been 
randomly selected and scattered equally over the targeted area. Attempts to randomly select 
these study areas were made but unfortunately discarded on site due to technical issues regard-
ing randomization software. Instead areas were chosen together with our local supervisor with 
help from the extension officers assisting us in the field. While choosing areas in an un-ran-
domized fashion, the risk of bias was considered at all times and the following data collection 
and subsequent analysis was performed with this risk in mind.  
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Seroprevalence of PPR antibodies in animals of age 3-12 months were lower in the group that 
according to farmers were in contact with wildlife compared to the group that did not have 
contact with wildlife. Though this result is not statistically significant, it is indeed interesting. 
The result might support a hypothesis that by having contact with wildlife, a sheep or goat suffer 
less risk of being infected with PPRV. This is not probable. Instead the lower seroprevalence 
in sheep and goat with wildlife contact is likely due to other factors, one of which is the different 
styles of livestock keeping. 
In the section where FP absorbance level was evaluated (4.2.1) the importance of how raising 
the cutoff value includes false negative samples was illustrated in Figure 3. This figure demon-
strates how FP results scatter in relation to the level of optical density. Low OD results in an 
aggregated cluster of results from both whole blood and serum in both types of filter paper, 
while high OD results in a much more scattered cluster. The figure also indicates a small but 
important difference in the OD results from FP saturated in whole blood compared to FP satu-
rated in serum. The FP saturated in serum is consistently closer to the original serum sample 
OD result than corresponding whole blood sample. Even if the statistical confidence is missing 
in this observation, I believe that this difference between whole blood saturation and serum 
saturation must be taken in to account. Not doing so would make the FP results under-appreci-
ated in relation to the serum sample results.  
The use of Cohen’s kappa and Weighted Cohen’s kappa showed to what extent the results from 
the two different kinds of FP agreed with the serum sample results. A number of points regard-
ing this analysis and its results can be discussed. The two coefficients implied that both filter 
papers reached the highest level of agreement to the serum sample results. According to the 
confidence intervals though, both the Nobuto and Sartorius FP result overlap the “good” to 
“substantial” classifications on the internationally recognized scale of measurement. This 
means that both FP might agree with the serum sample results only to the second highest clas-
sification. Ideally, the CI would have been a span narrow enough for the kappa result not to 
overlap between the “good” (0.6-0.8) and “substantial” (0.8-1) classification threshold. There 
are two ways to make the CI span more narrow: First, to lower the CI from 95% to 90%. This 
would result in a narrower confidence interval but at the cost of the assurance of it by 5%, 
making the result less accurate on the other end.  Second, increasing the number of observations. 
This would result in a smaller confidence interval without being at a cost of anything else. This 
would be the ideal solution if it had been practically possible. Unfortunately, increasing the 
number of observations probably would have resulted in field related issues or budget and time 
limitations. With the current setup, an increased number of FP samples would most likely have 
resulted in a lower number of serum samples in this study. In hindsight it is difficult to say 
which of the two would have been better or worse for the result.  
The difference between Cohen’s kappa and Weighted Cohen’s kappa should not be left un-
touched. As mentioned earlier, these methods evaluate the agreement between two different 
methods in the categorizing of data (Cohen, 1968). These two methods are variants of same 
principles but differ in how different levels of disagreement are valued. Cohen’s kappa takes 
agreements versus disagreements into account in a black and white fashion while Weighted 
Cohen’s kappa values a disagreement different depending on its severity. In this case, a nega-
tive/positive situation is valued higher than a doubtful/negative or doubtful/positive situation. 
With this in mind, the Weighted Cohen’s kappa is the most suited method of the two of them 
in this evaluation. With that being said, this study is unfortunately not free from the burden of 
inaccuracy. Therefore both of these statistical methods are used in parallel to complement the 
statistical evaluation. 
Throughout the analysis of FP and serum samples I have at all times used the serum sample 
result as a gold standard. I did this since the cELISA on serum was the most accurate method 
at hand. Nevertheless, there could have been issues with this method that compromises some 
of these results. The reason to this FP evaluation is partly to enlighten the issues of keeping a 
continuous cool chain from when the sample is taken to analysis in parts of the world where 
infrastructure and new technology are faltering or missing. Now, it would be easy to assume 
that my team and me were exposed to these kinds of issues. Furthermore, could these issues 
have compromised the samples? And, in this case, how would this affect the samples in relation 
to the seroprevalence? A lower seroprevalence from serum sample results would give, not only 
a falsely low seroprevalence, but also giving the illusion of FP results being closer to the per-
ceived true seroprevalence, hence giving them a false high result.  
5.1 Conclusion 
This study showed a PPRV antibody seroprevalence of 3.3% in sheep and goats of age 3-12 
months in three areas adjacent to Selous Game Reserve in the region of Morogoro, Tanzania.  
This study also showed that FP could be a viable alternative to serum samples and successive 
serology in areas where keeping a sustained cold chain is problematic. Furthermore, arguments’ 
showing how the interpretation of FP results could refine and supplement the identification of 
samples containing antibodies against PPRV was presented.  
It is of great interest to further evaluate the use of FP as an alternative to serum samples in PPR 
serology to assist the study of PPR in remote areas. A supplementary study with additional 
observations is suggested to be able to make an accurate suggestion to a change in cutoff value 
for a certain filter paper.  
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